{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:59:44Z","timestamp":1780448384106,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T00:00:00Z","timestamp":1155168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,11,16]]},"DOI":"10.1007\/s00296-006-0168-6","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T13:44:43Z","timestamp":1155131083000},"page":"183-185","source":"Crossref","is-referenced-by-count":14,"title":["Cyclosporine A as treatment of esophageal involvement in dermatomyositis"],"prefix":"10.1007","volume":"27","author":[{"given":"Sumiyuki","family":"Mii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Niiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Katsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,10]]},"reference":[{"key":"168_CR1","first-page":"1336","volume":"25","author":"I Marie","year":"1998","unstructured":"Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B (1998) Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 25:1336\u20131343","journal-title":"J Rheumatol"},{"key":"168_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","volume":"18","author":"I Marie","year":"1999","unstructured":"Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U et al (1999) Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 18:139\u2013147","journal-title":"Medicine (Baltimore)"},{"key":"168_CR3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00002281-199711000-00003","volume":"9","author":"BC Sonies","year":"1997","unstructured":"Sonies BC (1997) Evaluation and treatment of speech and swallowing disorders associated with myopathies. Curr Opin Rheumatol 9:486\u2013495","journal-title":"Curr Opin Rheumatol"},{"key":"168_CR4","first-page":"207","volume":"4","author":"JR Carpenter","year":"1977","unstructured":"Carpenter JR, Bunch TW, Engel AG, O\u2019Brien PC (1977) Survival in polymyositis: corticosteroids and risk factors. J Rheumatol 4:207\u2013214","journal-title":"J Rheumatol"},{"key":"168_CR5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00002281-199411000-00008","volume":"5","author":"MC Dalakas","year":"1994","unstructured":"Dalakas MC (1994) Current treatment of inflammatory myopathies. Curr Opin Rheumatol 5:595\u2013601","journal-title":"Curr Opin Rheumatol"},{"key":"168_CR6","doi-asserted-by":"crossref","first-page":"70S","DOI":"10.1007\/BF01540896","volume":"15","author":"MC Dalakas","year":"1995","unstructured":"Dalakas MC (1995) Update of the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. J Clin Immunol 15:70S\u201375S","journal-title":"J Clin Immunol"},{"key":"168_CR7","first-page":"828","volume":"19","author":"S Herson","year":"1992","unstructured":"Herson S, Cherin P, Coutellier A (1992) The association of plasma exchange synchronized with intravenous gamma globulin therapy in severe intractable polymyositis. J Rheumatol 19:828\u2013829","journal-title":"J Rheumatol"},{"key":"168_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-5728(97)00033-7","volume":"76","author":"S Matsubara","year":"1997","unstructured":"Matsubara S, Hirai S, Sawa Y (1997) Pulsed intravenous methylprednisolone therapy for inflammatory myopathies: evaluation of the effect by comparing two consecutive biopsies from the same muscle. J Neuroimmunol 76:75\u201380","journal-title":"J Neuroimmunol"},{"key":"168_CR9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00002281-199611000-00008","volume":"8","author":"L Villalba","year":"1996","unstructured":"Villalba L, Adams EM (1996) Update of therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 8:544\u2013551","journal-title":"Curr Opin Rheumatol"},{"key":"168_CR10","first-page":"2706","volume":"26","author":"I Marie","year":"1999","unstructured":"Marie I, Hachulla E, Levesque H, Reumont G, Ducrotte P, Cailleux N et al (1999) Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol 26:2706\u20132709","journal-title":"J Rheumatol"},{"key":"168_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0889-857X(05)70266-0","volume":"22","author":"DE Yocum","year":"1996","unstructured":"Yocum DE (1996) Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheum Dis Clinics North Am 22:133\u2013154","journal-title":"Rheum Dis Clinics North Am"},{"key":"168_CR12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00002281-199811000-00001","volume":"10","author":"FW Miller","year":"1998","unstructured":"Miller FW (1998) Myositis and myopathies [editorial]. Curr Opin Rheumatol 10:499\u2013503","journal-title":"Curr Opin Rheumatol"},{"issue":"suppl 1","key":"168_CR13","first-page":"S15","volume":"10","author":"SB Kaye","year":"1998","unstructured":"Kaye SB (1998) Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention. Curr Opin Oncol 10(suppl 1):S15\u2013S19","journal-title":"Curr Opin Oncol"},{"key":"168_CR14","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/endo.139.4.5917","volume":"139","author":"OC Meijer","year":"1998","unstructured":"Meijer OC, De Lange ECM, Breimer DD, De Boer AG, Workel JO, De Kloet ER (1998) Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1a P-glycoprotein knockout mice. Endocrinology 139:1789\u20131793","journal-title":"Endocrinology"},{"key":"168_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0966-842X(02)00010-0","volume":"11","author":"KS Mckeegan","year":"2003","unstructured":"Mckeegan KS, Borges-Walmsley MI, Walmsley AR (2003) The structure and function of drug pumps: an update. Trends Microbiol 11:21\u201329","journal-title":"Trends Microbiol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-006-0168-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-006-0168-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-006-0168-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:16:03Z","timestamp":1559042163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-006-0168-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,10]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11,16]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1007\/s00296-006-0168-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,10]]}}}